Published in Med Phys on June 17, 1993
An imaging-driven model for liposomal stability and circulation. Mol Pharm (2010) 1.05
Pretargeted radioimmunotherapy for hematologic and other malignancies. Cancer Biother Radiopharm (2010) 0.86
Dosimetric effectiveness of targeted radionuclide therapy based on a pharmacokinetic landscape. Cancer Biother Radiopharm (2010) 0.82
Pharmacokinetic analysis of the microscopic distribution of enzyme-conjugated antibodies and prodrugs: comparison with experimental data. Br J Cancer (1996) 0.81
Evidence for a Sex-Linked Haplo-Inviable Locus in the Cut-Singed Region of DROSOPHILA MELANOGASTER. Genetics (1973) 2.45
Magnetic resonance imaging measurements and clinical changes accompanying transtentorial and foramen magnum brain herniation. Ann Neurol (1993) 1.65
A clinally varying promoter polymorphism associated with adaptive variation in wing size in Drosophila. Mol Ecol (2010) 1.55
Lethal(1) aberrant immune response mutations leading to melanotic tumor formation in Drosophila melanogaster. Dev Genet (1991) 1.48
Antimyosin antibody imaging in experimental aortic regurgitation. J Nucl Cardiol (1997) 1.42
Medical physics graduate programs should focus on education and research and leave clinical training to residencies. Med Phys (1999) 1.40
Predicting myelotoxicity in radioimmunotherapy: what does dosimetry contribute? J Nucl Med (1997) 1.40
Biologic bypass with the use of adenovirus-mediated gene transfer of the complementary deoxyribonucleic acid for vascular endothelial growth factor 121 improves myocardial perfusion and function in the ischemic porcine heart. J Thorac Cardiovasc Surg (1998) 1.37
Abdominal organ segmentation using texture transforms and a Hopfield neural network. IEEE Trans Med Imaging (1999) 1.35
A stereotactic method for the three-dimensional registration of multi-modality biologic images in animals: NMR, PET, histology, and autoradiography. Med Phys (2003) 1.31
Mobile elements and transposition events in the cut locus of Drosophila melanogaster. Mol Gen Genet (1989) 1.14
Ribosomal protein S14 is encoded by a pair of highly conserved, adjacent genes on the X chromosome of Drosophila melanogaster. Mol Cell Biol (1988) 1.03
Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121. Ann Thorac Surg (2000) 0.97
Radioimmunotherapy of micrometastases: a continuing evolution. J Nucl Med (1992) 0.97
Hybrid dysgenesis in Drosophila: the mechanism of T-007-induced male recombination. Mol Gen Genet (1981) 0.95
On measuring hypoxia in individual tumors with radiolabeled agents. J Nucl Med (2001) 0.94
Efficient transfer of proteins from acetic acid-urea and isoelectric-focusing gels to nitrocellulose membrane filters with retention of protein antigenicity. Anal Biochem (1983) 0.91
Salvage angiogenesis induced by adenovirus-mediated gene transfer of vascular endothelial growth factor protects against ischemic vascular occlusion. J Vasc Surg (1998) 0.90
Torsion of the upper lobe in pneumothorax. Radiology (1989) 0.86
Latitudinal and cold-tolerance variation associate with DNA repeat-number variation in the hsr-omega RNA gene of Drosophila melanogaster. Heredity (Edinb) (2008) 0.84
Improved tumor imaging with radiolabeled monoclonal antibodies by plasma clearance of unbound antibody with anti-antibody column. Radiology (1991) 0.84
A silver-staining technique for detecting minute quantities of proteins on nitrocellulose paper: retention of antigenicity of stained proteins. Anal Biochem (1982) 0.83
PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites. Oncogene (2001) 0.83
External imaging of atherosclerosis in rabbits using an 123I-labeled synthetic peptide fragment. J Clin Pharmacol (1993) 0.82
Prospective study of simultaneous orthoiodohippurate and diethylenetriaminepentaacetic acid captopril renography. The Einstein/Cornell Collaborative Hypertension Group. J Nucl Med (1998) 0.81
Thyroid uptake of liquid versus capsule 131I tracers in hyperthyroid patients treated with liquid 131I. Thyroid (1999) 0.79
The differential sensitivity of T-cell and B-cell mitogenesis to in vitro zinc deficiency. Cell Immunol (1981) 0.78
An improved radiolabeling technique of ivalon and its use for dynamic monitoring of complications during therapeutic transcatheter embolization. J Nucl Med (1989) 0.78
Biodistribution and autoradiographic localization of I-125--labeled synthetic Peptide in aortic atherosclerosis in cholesterol-fed rabbits. Am J Ther (1996) 0.77
Potassium iodide for thyroid blockade in a reactor accident: administrative policies that govern its use. Thyroid (1997) 0.76
An alternative to Monte Carlo in determining release criteria for patients administered radioactive material. Health Phys (1999) 0.75
Correlation of Fourier spectral shift-determined hepatic acoustic attenuation coefficients with liver biopsy findings. J Ultrasound Med (1989) 0.75
The "Harlequin" artifact: cause and correction. J Nucl Med (1989) 0.75
In vitro evaluation of the relative thrombolytic efficiency of forced intrathrombic injections: saline versus urokinase. J Vasc Interv Radiol (1998) 0.75
In vitro model to evaluate the relative efficacy of catheter-directed thrombolytic strategies. Acad Radiol (1996) 0.75
A pharmacokinetic model describing the removal of circulating radiolabeled antibody by extracorporeal immunoadsorption. J Pharmacokinet Biopharm (1991) 0.75
Dosimetry of solid tumors. Med Phys (1993) 0.75
Filling gaps in the continuum. Fourth in a series examining revenue growth strategies in a difficult health care market. Health Prog (2001) 0.75
Effect of prior radiopharmaceutical administration on Schilling test performance: analysis and recommendations. J Nucl Med (1996) 0.75
Clinical comparison of high-resolution with high-sensitivity collimators in low-count cardiac gated blood pool studies. Am J Physiol Imaging (1988) 0.75
ICRP Publication 140: Radiological Protection in Therapy with Radiopharmaceuticals. Ann ICRP (2019) 0.75
Early description of "bull's-eye" plot for emission cardiac tomography. J Nucl Med (1988) 0.75
Eighteen-month clinical experience with extended wear silicone contact lenses on 400 patients. Am J Optom Physiol Opt (1983) 0.75
111In-DTPA cisternography to investigate a possible cerebrospinal fluid (CSF) leak. J Nucl Med (1995) 0.75
Returning to revenue growth. A new series examines five revenue growth strategies in a difficult health care market. Health Prog (2001) 0.75
Increasing market share. Second in a series examining revenue growth strategies in a difficult health care market. Health Prog (2001) 0.75
Expanding service area. Third in a series examining revenue growth strategies in a difficult health care market. Health Prog (2001) 0.75